Diabetes doesn't take a day off. So Perry Health built a care system that doesn't either - a connected meter, unlimited strips, and a human who calls to check in.
Somewhere in one of twenty states, a 72-year-old checks her blood sugar. The reading leaves the meter and lands - over a cellular signal, no Wi-Fi, no app to fumble with - on the screen of a care team that already knows her name. By the afternoon, a coach has texted. This is Tuesday. It will also be Wednesday.
That ordinary loop is the entire product. Perry Health is a New York digital-health company that manages type 2 diabetes the way diabetes actually behaves: continuously. Members get a connected blood glucose meter, unlimited test strips shipped to the door, and a standing relationship with clinicians, dietitians, and accountability coaches who watch the numbers seven days a week.
It is, in the company's own unfussy phrasing, an attempt to build "the world's first remote, continuous health system for patients living with chronic disease." Grand wording for what feels, on the receiving end, like someone finally paying attention.
Here is the inconvenient arithmetic. A person with type 2 diabetes makes hundreds of small decisions a year - what to eat, when to test, whether to walk. The traditional health system meets them for roughly fifteen minutes, two or three times in that same year. The other 99.9% of the disease happens unobserved.
The cost of that gap shows up later, expensively: complications, hospitalizations, and an A1C number that drifts because nobody was watching it drift. For seniors on Medicare, the people Perry serves, the stakes are highest and the support is often thinnest.
The skeptic's question is fair. Hasn't everyone promised to fix this with an app? Plenty have. The difference Perry bet on was not software for its own sake - it was using the connectivity to keep a human in the loop, every day, for the people least likely to download anything.
Perry Health was founded in 2018 by Pan Chaudhury and Scott Chesrown. Chaudhury, the CEO, came in convinced that technology-driven continuous care could improve outcomes and lower costs at the same time - the rare combination that healthcare keeps promising and rarely delivers.
Chesrown, the COO, brought an operator's resume: he had previously co-founded an e-commerce company that went public on NASDAQ before turning to healthtech. Useful, it turns out, when your business depends on shipping physical supplies to thousands of homes and never running out.
The wager was simple to state and hard to execute. Instead of selling a device or a one-off coaching app, Perry would knit hardware, reimbursement, and human care into a single subscription the patient never sees a bill for. Get all three right, and the model works. Get one wrong, and it's just another gadget in a drawer.
Pan Chaudhury and Scott Chesrown start Perry Health in New York to build continuous, remote care for chronic disease.
Early backing from Primary Venture Partners and Lerer Hippeau funds the first connected-care cohorts.
A Series A round brings total funding to roughly $26M, with Left Lane Capital, General Catalyst and StepStone Group joining the cap table.
Perry's diabetes program crosses into its 20th state, a milestone in its national expansion.
Named to Digital Health New York's annual list of leading digital health companies.
A clinician runs the first review and pairs each member with a coach. A cellular meter and supplies arrive. Goals get set, check-ins get scheduled, and the numbers start to move. The hardware is the easy part - the standing relationship is the product.
A cellular meter that sends readings automatically to the care team - no smartphone, no Wi-Fi, no setup.
Unlimited test strips and lancets shipped to the door, at no out-of-pocket cost on eligible Medicare plans.
Clinician-supervised care with dietitians and accountability coaches for 1:1 support and goal-setting.
Seven-day-a-week monitoring with texts, calls and scheduled check-ins between visits.
*On eligible Medicare and Medicare Advantage plans. Coverage falls under Medicare Part B.
Across its membership, Perry reports an average 2.5-point reduction in A1C within the first 12 months. For context, clinicians tend to get excited about fractions of a point. Whether that figure holds at larger scale is exactly the question the next few years will answer - and the company seems content to be judged on it.
The validation isn't only clinical. Investors including Left Lane Capital, General Catalyst, Primary Venture Partners, Lerer Hippeau and StepStone Group have put in roughly $26M. Medicare covers the service. And in 2024, Digital Health New York added Perry to its DH100 - the local list of companies actually shipping, not just pitching.
Perry's stated mission is to bring whole-person specialist care to underserved people living with chronic disease. Read closely, the word doing the work is "underserved." Diabetes care has no shortage of premium options for people with means and time. Perry pointed itself at Medicare seniors instead - the population with the most to lose and the least continuous support.
It's a less glamorous market than it sounds in a pitch deck, and that may be the point. The company isn't trying to reinvent the glucometer. It's trying to reinvent the days between the doctor visits, which is where chronic disease is actually won or lost.
Diabetes is the proving ground, not the destination. The architecture Perry is building - connected device, covered supplies, continuous human care, all under one reimbursed roof - is a template. Hypertension, kidney disease, heart failure: every chronic condition shares the same flaw of being managed in fifteen-minute increments. Solve the operating system once and the conditions become almost interchangeable.
The skeptic still gets the last word, and should: scaling human-led care is hard, margins in Medicare are tight, and outcome claims need years to harden. But Perry has chosen to compete on the one thing that's hard to fake - whether the numbers move.